Efficacy of fluvastatin and aspirin for prevention of hormonally insensitive breast cancer.
Anjana BhardwajMatthew D EmburyRaniv D RojoConstance AlbarracinIsabelle BedrosianPublished in: Breast cancer research and treatment (2021)
In line with NCI's emphasis to repurpose low-toxicity drugs for prevention of cancer, fluvastatin was effective for prevention of TNBC and warrants further clinical testing. Aspirin did not provide chemopreventive benefit.